{"SPADE_UN_18792": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_18792", "Peptide Name": "GLRC-6 (Synthetic AMPs, variant of GLR-19, Arg-rich; Leu-rich; 1S=S, UCSS1a)", "Source": "De novo designed, man-made sequences", "Family": "Not found", "Gene": "Not found", "Sequence": "CRLGRLLRRLGRCLLR", "Sequence Length": 16, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Antiviral", "Anti-HIV"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 1954.46, "PI": 12.0, "Hydrophobicity": -0.0, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Wang G, Watson KM, Mishra B, Lushnikova T, Buckheit RW Jr. 2011", "Reference": "J AIDS Clinic Res S2:003. doi:10.4172/2155-6113.S2-003.Wang HIV screen project", "Title": "De Novo Design of Antiviral and Antibacterial Peptides with \nVarying Loop Structures"}], "Frequent Amino Acids": "LRC", "Absent Amino Acids": "ADEFHIKMNOPQSTUVWY", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 8, "Positive Residues": 6, "Negative Residues": 0, "Net Charge": 6, "Comments": "Sequence analysis: APD analysis reveals that this sequence is poorly similar (84.21%) toGLRC-2. R: 38%; L: 38%.; G=C: 13%.Chemical modification:  one disulfide bond C1-C13.Activity: inhibited E. coli (MIC 60 uM); B. subtilis (MIC 60 uM).Toxicity: TC50 >100 ug/ml in CEM-SS cells.", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_18789", "Similarity": 1.0, "Sequence": "GLRCRLGRLLRRLGRCLLR"}, {"SPADE_ID": "SPADE_UN_18793", "Similarity": 1.0, "Sequence": "GLRCRLGRLLRRLGRC"}, {"SPADE_ID": "SPADE_N_07290", "Similarity": 1.0, "Sequence": "LLR"}]}}}